February 3, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, today announced a defining milestone in its institutional journey with the appointment of Holger [...]
More news
In 2025, it is possible — and increasingly common — to treat cancer but lose [...]
At INCATE, we are committed to providing support to early-stage innovators working on antimicrobial resistance [...]
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its debut on the SIX Swiss [...]
On the evening of April 9, 2025, The Voltahalle in Basel was the stage of [...]
AdjuTec Pharma AS - 3rd place winner of the Poster Competition at the 9th AMR [...]
INCATE kicked off the AMR week in Basel with the INCATE Networking Event on February [...]
Our colleague Helmut Kessmann has decided his time has come to retire and embark on new [...]
The INCATE Selection Committee selected the new 4 ventures for Stage I support. Meet the [...]
